Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathwayChieh-Yu Shen, Ko-Jen Li, Pei-Hsuan Lai, Chia-Li Yu, Song-Chou HsiehClinical Rheumatology20171 Excerpt
Extended Periarterial Sympathectomy: Evaluation of Long-Term Outcomes.Collier S Pace, Wyndell H MerrittHand2017
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosisCelestina Mazzotta, Eloisa Romano, +7 authors Serena GuiducciArthritis research & therapy20151 Excerpt
Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.F Gaillard-Bigot, M Roustit, +6 authors J L CracowskiMicrovascular research20141 Excerpt
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedinSonja Hetzer, Bettina Alexandra Buhren, +5 authors Bernhard HomeyEuropean journal of medical research20141 Excerpt
Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic SclerosisSergio A. JimenezISRN rheumatology20131 Excerpt
Platelet activation in patients with the Raynaud phenomenon.L Polidoro, R Barnabei, P Giorgini, L Petrazzi, C Ferri, G ProperziInternal medicine journal2012
Raynaud’s phenomenon and vitamin DJosiane Hélou, Roy Moutran, Ismael Maatouk, Fady HaddadRheumatology International20121 Excerpt
Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic studyFranco Cozzi, Giancarlo Parisi, +5 authors Leonardo PunziRheumatology International20101 Excerpt
Recent achievements in the management of Raynaud’s phenomenonMagnus Baumhäkel, Michael BöhmVascular health and risk management2010